共 50 条
- [1] Comparison of the efficacy and safety of tofacitinib and upadacitinib in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials[J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (08) : 1563 - 1571Song, Gwan GyuChoi, Sung JaeLee, Young Ho
- [2] Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (06): : 590 - 603Lee, Y. H.Song, G. G.
- [4] Comparison of the efficacy and safety of tofacitinib and mavrilimumab in patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (08) : 557 - 565Sung, Yoon-KyoungLee, Young Ho
- [5] Comparison of the efficacy and safety of tofacitinib and baricitinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials[J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (06): : 559 - 567Bae, S-CLee, Y. H.
- [6] RELATIVE EFFICACY AND SAFETY OF TOFACITINIB, BARICITINIB, UPADACITINIB, AND FILGOTINIB, IN COMPARISON WITH ADALIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1001 - 1001Lee, Y. H.Song, G. G.
- [8] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials[J]. Clinical Drug Investigation, 2019, 39 : 421 - 428Gwan Gyu SongYoung Ho Lee
- [10] Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials[J]. RHEUMATOLOGY INTERNATIONAL, 2015, 35 (12) : 1965 - 1974Lee, Young HoBae, Sang-CheolSong, Gwan Gyu